Last reviewed · How we verify
NCT04538274
Trained Patient Involvement to Promote the Resumption of CPAP in Patients Who Have Discontinued Its Use
NA trial testing peer-driven intervention in Obstructive Sleep Apnea Syndrome in 208 participants. Not yet recruiting.
18 February 2025
Quick facts
| Lead sponsor | AGIR à Dom |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 208 |
| Start date | 18 February 2025 |
| Primary completion | 18 February 2025 |
| Estimated completion | 18 February 2025 |
Drugs / interventions tested
- peer-driven intervention
Conditions studied
- Obstructive Sleep Apnea Syndrome — all drugs for Obstructive Sleep Apnea Syndrome →
Sponsor
AGIR à Dom
Who can join
Adults 18 to 120, any sex, with Obstructive Sleep Apnea Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this randomized clinical trial is to evaluate the role of patient researchers in promoting the resumption of CPAP therapy in apneic patients who had previously stopped CPAP
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Shared decision-making interventions for people with mental health conditions.
Aoki Y, Yaju Y, Utsumi T, Sanyaolu L, et al · · 2022 · cited 34× · PMID 36367232 · DOI 10.1002/14651858.cd007297.pub3 -
Peer-driven intervention to help patients resume CPAP therapy following discontinuation: a multicentre, randomised clinical trial with patient involvement.
Merle R, Pison C, Logerot S, Deschaux C, et al · · 2021 · cited 6× · PMID 34649850 · DOI 10.1136/bmjopen-2021-053996
Verify or expand the search:
- PubMed search for NCT04538274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea Syndrome
Currently open trials in the same condition.
- NCT05147649 — Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome · NA · recruiting
Other AGIR à Dom trials
Trials by the same sponsor.
- NCT05653804 — Impact of Tele-visit on Patients Continous Positive Airway Pressure (CPAP) Follow-up by Home Care Provider · NA · active not recruiting
- NCT05621213 — Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation · NA · terminated
- NCT04925739 — Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome · completed
- NCT04716985 — Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Trea · NA · unknown
- NCT02699918 — Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma · EARLY_PHASE1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04538274 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AGIR à Dom
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04538274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing